Correlation Between Palisade Bio and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Crispr Therapeutics AG, you can compare the effects of market volatilities on Palisade Bio and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Crispr Therapeutics.
Diversification Opportunities for Palisade Bio and Crispr Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Palisade and Crispr is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Palisade Bio i.e., Palisade Bio and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Palisade Bio and Crispr Therapeutics
Given the investment horizon of 90 days Palisade Bio is expected to under-perform the Crispr Therapeutics. In addition to that, Palisade Bio is 2.56 times more volatile than Crispr Therapeutics AG. It trades about -0.03 of its total potential returns per unit of risk. Crispr Therapeutics AG is currently generating about -0.03 per unit of volatility. If you would invest 6,673 in Crispr Therapeutics AG on August 26, 2024 and sell it today you would lose (1,885) from holding Crispr Therapeutics AG or give up 28.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Palisade Bio vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Palisade Bio |
| Crispr Therapeutics |
Palisade Bio and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Palisade Bio and Crispr Therapeutics
The main advantage of trading using opposite Palisade Bio and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Altamira Therapeutics | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences |
| Crispr Therapeutics vs. Eliem Therapeutics | Crispr Therapeutics vs. HCW Biologics | Crispr Therapeutics vs. Scpharmaceuticals | Crispr Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |